Midostaurin
Rydapt
Treatment Description
Midostaurin is a multitarget protein kinase inhibitor that inhibits some proteins that cancer cells need to grow, and may cause cancer cell death.
Participating Centers
There are 31 centers running trials with this treatment. Enter a location below to find the closest center.